(Reuters) -Medical device maker Boston Scientific said on Friday it will buy the remaining equity in privately held Nalu Medical for about $533 million in cash, expanding its treatments for chronic ...
Assessing all available nonhormonal and hormonal therapies for vasomotor symptoms helps empower women to make informed ...
The results of a phase 3 trial of Vertanical's cannabis-derived therapy VER-01 for chronic lower back pain have been published, and bode well for the ongoing reviews of marketing applications for the ...
Patients suffering from back pain have enjoyed life-changing results thanks to a new implant, according to a doctor. The ...
5don MSN
Experts Say This Wellness Tool Can Make You Happier and Ease Pain—But Only If You Use It Properly
Bookings for sauna sits were in the top five of ClassPass’s wellness reservations last year, and one research firm predicts ...
Trump's approval edges up despite Americans blaming Republicans for shutdown Americans blame Republican lawmakers more than Democratic lawmakers for a partial government shutdown, according to a new ...
Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback